M. Wechsler, A. Menzies-Gow, C. Brightling, N. Martin, B. Cook, P. Kabelis, T. Piechowiak, I. Cąpała-Szczurko, K. Sałapa, N. Molfino, Y. Chon, H. Lal, G. Colice
{"title":"SUNRISE:一项评估Tezepelumab减少OCS依赖严重哮喘患者使用OCS的有效性和安全性的3期平行组研究","authors":"M. Wechsler, A. Menzies-Gow, C. Brightling, N. Martin, B. Cook, P. Kabelis, T. Piechowiak, I. Cąpała-Szczurko, K. Sałapa, N. Molfino, Y. Chon, H. Lal, G. Colice","doi":"10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a1295","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":297069,"journal":{"name":"A31. GLOBAL AND ENVIRONMENTAL INFLUENCES IN ASTHMA","volume":"34 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"SUNRISE: A Phase 3, Parallel-group Study to Evaluate the Efficacy and Safety of Tezepelumab in Reducing OCS Use in OCS-dependent Patients With Severe Asthma\",\"authors\":\"M. Wechsler, A. Menzies-Gow, C. Brightling, N. Martin, B. Cook, P. Kabelis, T. Piechowiak, I. Cąpała-Szczurko, K. Sałapa, N. Molfino, Y. Chon, H. Lal, G. Colice\",\"doi\":\"10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a1295\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":297069,\"journal\":{\"name\":\"A31. GLOBAL AND ENVIRONMENTAL INFLUENCES IN ASTHMA\",\"volume\":\"34 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"A31. GLOBAL AND ENVIRONMENTAL INFLUENCES IN ASTHMA\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a1295\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"A31. GLOBAL AND ENVIRONMENTAL INFLUENCES IN ASTHMA","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a1295","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
SUNRISE: A Phase 3, Parallel-group Study to Evaluate the Efficacy and Safety of Tezepelumab in Reducing OCS Use in OCS-dependent Patients With Severe Asthma